Epigral reported a mixed set of numbers for the quarter ended March 31, 2026 (Q4 FY26), where revenue growth remained strong on a year-on-year (YoY) basis, but profitability came under pressure due to rising expenses.
On the operational front, revenue from operations stood at ₹736.16 crore in Q4 FY26 compared to ₹627.63 crore in Q4 FY25, registering a solid growth of 17.3%. Total income also increased by 16.6% YoY to ₹735.59 crore from ₹631.03 crore in the corresponding quarter last year. However, other income turned negative at ₹(0.57) crore versus ₹3.40 crore YoY, slightly impacting overall earnings.
The cost side remained elevated during the quarter. Total expenses rose sharply by 25.0% YoY to ₹625.07 crore, compared to ₹499.97 crore in Q4 FY25. This increase in expenses outpaced revenue growth, which weighed on margins.
As a result, profit before tax (PBT) declined 15.7% YoY to ₹110.52 crore from ₹131.06 crore. Profit after tax (PAT) also fell 6.8% YoY to ₹80.95 crore compared to ₹86.89 crore in the same quarter last year.
For the full year FY26, Epigral reported a relatively stable top line but weaker profitability. Revenue from operations came in at ₹2,527.18 crore compared to ₹2,550.13 crore in FY25, marking a marginal decline of 0.9%. Total income also dipped 0.9% YoY to ₹2,542.16 crore.
Annual expenses increased by 8.7% YoY to ₹2,200.36 crore from ₹2,025.24 crore, continuing to exert pressure on earnings. Consequently, profit before tax dropped significantly by 36.7% YoY to ₹341.80 crore from ₹540.10 crore.
Despite the sharp fall in PBT, profit after tax declined by a relatively moderate 7.2% YoY to ₹331.97 crore compared to ₹357.69 crore in FY25, supported by lower tax outgo during the year.